Clinical Trials Browser

OTHER × Adenocarcinoma × Albumin-Bound Paclitaxel × Clear all

Adenocarcinoma, Pancreatic Neoplasms

NCT04543071 2025-06-19

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Phase 2 Recruiting

10 enrolled

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT03535727 2024-12-31

A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

Phase 1/2 Completed

48 enrolled 24 charts

Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Neoplasms, Neoplasms, Glandular and Epithelial, Pancreatic Diseases, Pancreatic Neoplasms

NCT03415854 2023-12-15

NABPLAGEMD

Phase 2 Completed

11 enrolled

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT01677559 2018-01-11

Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies

Phase 1 Completed

34 enrolled

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT01161186 2012-10-11

Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma

Phase 1 Completed

15 enrolled

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Clinical Trials

A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

NABPLAGEMD

Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies

Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma